2016年6月8日下午，丹麦诺和诺德公司与87978797威尼斯老品牌药事监管科学合作项目启动会在张江召开。专程从哥本哈根前来参会的诺和诺德公司副总裁戴瑞博博士、诺和诺德（中国）制药有限公司副总裁张克洲博士和优化集群管理经理孙超博士与87978797威尼斯老品牌院长王明伟研究员、副院长侯爱君教授、院长助理李嫣副教授、院长助理刘瑜博士和洪兰博士进行了深度交流。双方就近期及今后几年的工作目标、行动方案和时间节点等项目实施细节达成一致。美国奥尔伯尼药学和健康科学学院郑海安副教授应邀参加了讨论。会前，复旦大学副校长桂永浩教授亲切会见了丹麦贵宾。
Novo Nordisk-Fudan School of Pharmacy collaboration program initiated
In the afternoon of June 8, 2016, an initiation meeting relative to the Novo Nordisk-Fudan School of Pharmacy collaboration program on regulatory science was held in Zhangjiang. Present were Drs. Boerge Diderichsen (Vice President of Novo Nordisk) who specially flew over from Copenhagen for the meeting, Dr. Kezhou Zhang (Vice President) and Chao Jason Sun (Optimization Portfolio Manager) of Novo Nordisk (China) Pharmaceuticals, Inc., Professor Ming-Wei Wang (Dean), Professor Aijun Hou (Vice Dean), Associate Professor Yan Li (Assistant Dean), Drs. Yu Liu (Assistant Dean) and Lan Hong. They conducted an in-depth discussion concerning the execution details such as working goals, action plan and timeframe near term and in the next few years and reached an agreement. Associate Professor Haian Zheng from Albany College of Pharmacy and Health Sciences (U.S.A.) was invited to attend the discussion. Prior to the meeting, Professor Yonghao Gui (Vice Present of Fudan University) warmly greeted the Danish guest.
